Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1444
| Despition | VAMP2 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 95.0% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1736 | Human DYNLL1 Protein (AC1736) | 5 µg | inquiry |
| ACPP-1390 | Human GDF11 Protein, His (AC1390) | 5 µg | inquiry |
| ACPP-1383 | Human KLF7 Protein (AC1383) | 5 µg | inquiry |
| ACPP-1237 | CRMP1 Blocking Peptide (AC1237) | 250 µg | inquiry |
| ACPP-1556 | Human SMARCA4 Protein (AC1556) | 5 µg | inquiry |
| ACPP-1595 | Mouse DLL4 Protein (AC1595) | 2 µg | inquiry |
| ACPP-1164 | Synthetic Nanodisc Human GRPR Protein (AC1164) | 10 µg | inquiry |
| ACPP-1631 | Human IMPDH1 Protein (AC1631) | 2 µg | inquiry |
| ACPP-1835 | Human RP9 Protein (AC1835) | 5 µg | inquiry |
| ACPP-1030 | Recombinant Human Acetylcholinesterase Protein (6×His Tag) (AC1030) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.